Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. lowered its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 3.8% in the third quarter, Holdings Channel reports. The institutional investor owned 1,166,528 shares of the company’s stock after selling 46,460 shares during the quarter. JPMorgan Chase & Co.’s holdings in Option Care Health were worth $36,512,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Rhumbline Advisers lifted its stake in Option Care Health by 4.9% during the second quarter. Rhumbline Advisers now owns 572,665 shares of the company’s stock worth $15,863,000 after purchasing an additional 26,989 shares during the last quarter. Candriam S.C.A. grew its position in shares of Option Care Health by 4.2% during the 2nd quarter. Candriam S.C.A. now owns 237,555 shares of the company’s stock valued at $6,580,000 after buying an additional 9,471 shares during the last quarter. Norden Group LLC raised its stake in Option Care Health by 30.1% during the second quarter. Norden Group LLC now owns 19,689 shares of the company’s stock worth $545,000 after acquiring an additional 4,551 shares during the period. Quest Partners LLC lifted its holdings in Option Care Health by 5.6% in the second quarter. Quest Partners LLC now owns 22,962 shares of the company’s stock worth $636,000 after acquiring an additional 1,216 shares during the last quarter. Finally, Texas Permanent School Fund Corp boosted its stake in Option Care Health by 9.1% in the second quarter. Texas Permanent School Fund Corp now owns 169,178 shares of the company’s stock valued at $4,686,000 after acquiring an additional 14,155 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Trading Up 1.3 %

NASDAQ:OPCH opened at $23.88 on Tuesday. The stock has a fifty day simple moving average of $23.20 and a 200 day simple moving average of $27.81. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $4.06 billion, a price-to-earnings ratio of 20.07, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.63.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on OPCH shares. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and cut their target price for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. UBS Group began coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target for the company. Barrington Research cut their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. Finally, JMP Securities upped their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, Option Care Health currently has an average rating of “Hold” and an average price target of $30.14.

Insider Buying and Selling

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction dated Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.